Bandingkan Harga & Kinerja Cipta Perdana Lancar Tbk. (PART) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Cipta Perdana Lancar Tbk. dan Organon Pharma Indonesia Tbk.: Cipta Perdana Lancar Tbk. diperdagangkan di Rp102 (kapitalisasi pasar 293,61 M, volume 24 jam 6,37 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Cipta Perdana Lancar Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PART | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 293,61 M | 104,4 M |
Volume | 6,37 jt | — |
Lot | 63,66 rb | — |
Perputaran | 643,43 jt | — |
Harga Rata-rata | 101,07 | — |
Nilai Transaksi | 643,43 jt | — |
Harga Ekuilibrium Indikatif | 102 | — |
Volume Ekuilibrium Indikatif | 70 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Cipta Perdana Lancar Tbk.
PT. Cipta Perdana Lancar Tbk (the Company) was established based on Notarial Deed No. 02 of Lutfi Burhan, S.H., dated June 5, 2009, Notary in Jakarta. The Company started its commercial operations in June 2009.
Selengkapnya di halaman PART →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
